Brief: Oculis Announces Completion Of Enrollment In Phase 2 Randomized Controlled Acuity Trial With Ocs-05 For Acute Optic Neuritis

Oculis Holding AG

08/05/2024 21:43

May 8 (Reuters) - Oculis Holding AG  CR5.F :
    * OCULIS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2
RANDOMIZED
CONTROLLED ACUITY TRIAL WITH OCS-05 FOR ACUTE OPTIC NEURITIS
    * OCULIS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2
RANDOMIZED
CONTROLLED ACUITY TRIAL WITH OCS-05 FOR ACUTE OPTIC NEURITIS
    * OCULIS HOLDING AG - OCULIS ALSO AIMS TO COMPLETE AN IND
SUBMISSION FOR OCS-05 IN U.S. IN 2024

Source text for Eikon:  ID:nGNX6jjZX7 
Further company coverage:  CR5.F